The Claim
Among obese non-diabetic adults treated with liraglutide 3.0 mg for 1 year, experiencing at least one episode of nausea or vomiting is associated with an additional average weight loss of 2.9 kg compared to those without such symptoms (9.2 kg vs 6.3 kg, p=0.02).
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In obese non-diabetic adults taking liraglutide for one year, people who have nausea or vomiting lose about 2.9 kilograms more weight on average than those without these side effects. This means gastrointestinal side effects are linked to greater weight loss.
See the scientific wording
In obese non-diabetic adults treated with liraglutide 3.0 mg for 1 year, those who experience at least one episode of nausea or vomiting lose an additional 2.9 kg on average compared to those without such symptoms (9.2 kg vs 6.3 kg, p=0.02), indicating an association between gastrointestinal side effects and greater weight loss.
Liraglutide works like a natural hormone that tells the brain to stop eating. It activates special receptors in brain areas that control hunger and nausea. This makes people feel less hungry and, for some, causes nausea or vomiting. When people eat less because of reduced appetite or feeling sick, their body burns stored fat for energy, leading to more weight loss.
What the research says
1 studyThe study found that people taking liraglutide who felt sick lost about 20 pounds, while those who didn't lost about 14 pounds, a difference of about 6 pounds, which is exactly what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.